Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (1-10 of 1,279) with videos related to

Pageof 128
Sort By:
Alimentary Pharmacology & Therapeutics|September 2, 2025
Letter: "Tenofovir Alafenamide-The 'Star of Potential' for Long-Term Chronic Hepatitis B Treatment. A Deep-Dive Analysis of Phase 3 Clinical Trials." Authors' ReplyMaria Buti,
Annals of Hepatology|April 30, 2004
Current therapies for chronic hepatitis BMaria Buti
Idrugs : the Investigational Drugs Journal|April 2, 2008
Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conferenceMaria Buti
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?Maria Buti
Gastroenterologia Y Hepatologia|January 1, 1995
[Does hepatitis E exist in Europe?]M Buti
Gastroenterologia Y Hepatologia|August 2, 2001
[New perspectives in the treatment of chronic hepatitis C]M Buti
Anales De Medicina Interna (Madrid, Spain : 1984)|September 18, 2004
[Treatment with interferon of chronic hepatitis C in HIV-infected patients]M Buti
World Journal of Urology|May 23, 2018
A new prognostic model for localized renal cell carcinomaSebastiano Buti
Enfermedades Infecciosas Y Microbiologia Clinica|December 23, 2008
[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B]María Buti
Medicina Clinica|September 21, 1996
[Acute hepatitis E in Spain]M Buti
Pageof 128

Showing results (1-10 of 1,279) with videos related to

Sort By:
Pageof 128
Alimentary Pharmacology & Therapeutics|September 2, 2025
Letter: "Tenofovir Alafenamide-The 'Star of Potential' for Long-Term Chronic Hepatitis B Treatment. A Deep-Dive Analysis of Phase 3 Clinical Trials." Authors' ReplyMaria Buti,
Annals of Hepatology|April 30, 2004
Current therapies for chronic hepatitis BMaria Buti
Idrugs : the Investigational Drugs Journal|April 2, 2008
Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conferenceMaria Buti
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HBeAg-positive chronic hepatitis B: why do i treat my patients with Nucleos(t)ide analogs?Maria Buti
Gastroenterologia Y Hepatologia|January 1, 1995
[Does hepatitis E exist in Europe?]M Buti
Gastroenterologia Y Hepatologia|August 2, 2001
[New perspectives in the treatment of chronic hepatitis C]M Buti
Anales De Medicina Interna (Madrid, Spain : 1984)|September 18, 2004
[Treatment with interferon of chronic hepatitis C in HIV-infected patients]M Buti
World Journal of Urology|May 23, 2018
A new prognostic model for localized renal cell carcinomaSebastiano Buti
Enfermedades Infecciosas Y Microbiologia Clinica|December 23, 2008
[Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B]María Buti
Medicina Clinica|September 21, 1996
[Acute hepatitis E in Spain]M Buti
Pageof 128